Pathological Complete Response to Nivolumab, S1, Oxaliplatin, and Radiation in a Patient with Gastric Cancer: a Case Report

被引:0
作者
Kazuhiro Toyota
Yasushi Hashimoto
Yoshihiro Sakashita
Yujiro Yokoyama
Yoshiaki Murakami
Shinya Takahashi
Katsunari Miyamoto
机构
[1] Hiroshima Memorial Hospital,Department of Surgery
[2] Hiroshima University,Department of Surgery, Graduate School of Biomedical and Health Sciences
来源
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词
Gastric cancer; Nivolumab; S1 plus oxaliplatin; Radiation; Complete response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1000 / 1002
页数:2
相关论文
共 22 条
  • [1] Janjigian YY(2021)First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial Lancet 398 27-40
  • [2] Shitara K(2022)Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial Lancet Oncol 23 234-247
  • [3] Moehler M(2020)Clinical case of the neoadjuvant treatment with nivolumab in a patient with microsatellite unstable (MSI-H) locally advanced gastric cancer BMJ Case Rep 13 179-undefined
  • [4] Garrido M(2020)Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report World J Surg Oncol 18 undefined-undefined
  • [5] Salman P(undefined)undefined undefined undefined undefined-undefined
  • [6] Shen L(undefined)undefined undefined undefined undefined-undefined
  • [7] Kang Y-K(undefined)undefined undefined undefined undefined-undefined
  • [8] Chen L-T(undefined)undefined undefined undefined undefined-undefined
  • [9] Ryu M-H(undefined)undefined undefined undefined undefined-undefined
  • [10] Oh D-Y(undefined)undefined undefined undefined undefined-undefined